Gilteritinib

Gilteritinib

Gilteritinib (ASP2215) is a potent, ATP-competitive FLT3/AXL inhibitor with IC50s of 0.29 nM and 0.73 nM, respectively. It inhibits wild-type and mutant FLT3, including FLT3-ITD and FLT3-TKD variants, as well as Axl and c-Kit. Gilteritinib reduces the viability of blast cells from relapsed AML patients and is used in AML treatment. Reagent grade, for research use only.

Molecular structure of the compound BP-43655
    • Unit
    • Price
    • Qty
    • 50 MG
    • $150.00
    • 100 MG
    • $250.00
    • 250 MG
    • $450.00
    • 500 MG
    • $640.00

Usually ships within 24 hours.

Would you like to inquire about custom quantity?
Inquire